In this groundbreaking white paper, Panaceutics’ team of pharmacy and robotic technology experts examine the effects of pill burden on patients (poor adherence and outcomes) and the U.S. healthcare system ($290 billion in nonadherence costs per year), and the limitations of past polypill technologies in providing effective personalized solutions for variable population sizes.
Panaceutics reveals the future of personalized therapy technologies that simplify, customize, and scale complex prescription regimen delivery – through a single-dose, polytherapy puree pack. Panaceutics demonstrates how the innovative combination of modular automation concepts from the semiconductor industry and Good Manufacturing Practices of advanced pharmaceutical manufacturing, enable providers, patients and the healthcare system to significantly increase adherence while lowering associated costs.